Synapsen i Malmö AB

Active
559010-9202Limited company (AB)Registered 2015MALMÖ

Key figures

0 kr
Revenue 2025
020 k40 k60 k2019202020212022202320242025

Key figures

2025

Summary: Synapsen i Malmö AB

What kind of company is it?

Synapsen i Malmö AB (org. no. 559010-9202) is a limited company (AB). The company was registered in 2015 and has existed for 11 years. Registered seat: Malmö. Industry according to Statistics Sweden: specialised hospital somatic activities (SNI 86102).

How is the company doing financially?

The company had no net sales in financial year 2025. Net profit for 2025 was 202 604 kr. The company was profitable in 6 of the 7 reported financial years. According to the annual report, the company had no employees in financial year 2025. At the end of financial year 2025, total assets were 664 810 kr and equity 550 882 kr (equity ratio 82,9 %). The annual report for 2025 proposes a dividend of 500 000 kr.

Where does the data come from and how up to date is it?

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by one person. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.

Dividend

from the annual report
2025

Proposed dividend 500 000 kr.

History
2025500 000 kr
202370 000 kr
202270 000 kr
2020183 000 kr
Summary of annual reports2019–2025
20212022202320242025
Sales revenue58 00012 000000
Profit for the reporting year−20 37178 49659 84877 887202 604
Retained earnings of previous periods—————
Total assets824 960702 828618 597574 803664 810
Total liabilities452 913352 285278 206226 525113 928
Total equity372 047350 543340 391348 278550 882
Employees11000
Proposed dividend—70 00070 000—500 000

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.